Institut Català de la Salut
[Schubert KM, Bicciato G] Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Switzerland. [Zieglgänsberger D] Department of Neurology, Kantonsspital St. Gallen, Switzerland. [Abraira L, Santamarina E] Unitat d’Epilèpsia, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Álvarez-Sabín J] Epilepsy Unit, Unitat d’Epilèpsia, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Neurology, University of Muenster, Germany. Division for Neurodegenerative Diseases, Department of Neurology, Universitaetsmedizin Mannheim, University of Heidelberg, Germany
Vall d'Hebron Barcelona Hospital Campus
2025-07-07T06:45:46Z
2025-07-07T06:45:46Z
2025-07
Epilepsy; Seizures; Stroke
Epilepsia; Convulsiones; Ictus
Epilèpsia; Convulsions; Ictus
BACKGROUND: Acute symptomatic seizures (ASyS) increase the risk of epilepsy and mortality after a stroke. The impact of the timing and type of ASyS remains unclear. METHODS: This multicenter cohort study included data from 9 centers between 2002 and 2018, with a final analysis in February 2024. The study included 4552 adults (2005 female; median age, 73 years) with ischemic stroke and no seizure history. Seizures were classified using International League Against Epilepsy definitions. We examined ASyS occurring within 7 days after stroke. The main outcomes were all-cause mortality and epilepsy. Validation of the updated SeLECT score (SeLECT-ASyS) was performed in 3 independent cohorts (Switzerland, Argentina, and Japan) collected between 2012 and 2024, including 74 adults with ASyS. RESULTS: The 10-year risk of poststroke epilepsy ranged from 41% to 94%, and mortality from 36% to 100%, depending on ASyS type and timing. ASyS on stroke onset day had a higher epilepsy risk (adjusted hazard ratio [aHR], 2.3 [95% CI, 1.3–4.0]; P=0.003) compared with later ASyS. Status epilepticus had the highest epilepsy risk (aHR, 9.6 [95% CI, 3.5–26.7]; P<0.001), followed by focal to bilateral tonic-clonic seizures (aHR, 3.4 [95% CI, 1.9–6.3]; P<0.001). Mortality was higher in those with ASyS presenting as focal to bilateral tonic-clonic seizures on day 0 (aHR, 2.8 [95% CI, 1.4–5.6]; P=0.004) and status epilepticus (aHR, 14.2 [95% CI, 3.5–58.8]; P<0.001). The updated SeLECT-ASyS model, available as an application, outperformed a previous model in the derivation cohort (concordance statistics, 0.68 versus 0.58; P=0.02) and in the validation cohort (0.70 versus 0.50; P=0.18). CONCLUSIONS: ASyS timing and type significantly affect epilepsy and mortality risk after stroke, improving epilepsy prediction and guiding patient counseling.
Article
Published version
English
Convulsions; Epilèpsia - Mortalitat; Malalties cerebrovasculars - Complicacions; DISEASES::Nervous System Diseases::Neurologic Manifestations::Seizures; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Stroke; Other subheadings::Other subheadings::Other subheadings::/complications; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Epilepsy; Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality; PHENOMENA AND PROCESSES::Physical Phenomena::Time::Time Factors; ENFERMEDADES::enfermedades del sistema nervioso::manifestaciones neurológicas::convulsiones; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::accidente cerebrovascular; Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::epilepsia; Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad; FENÓMENOS Y PROCESOS::fenómenos físicos::tiempo::factores de tiempo
Wolters Kluwer Health
Stroke;56(7)
https://doi.org/10.1161/STROKEAHA.124.050045
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3437]